Evidence map›Paper›PMID 23755118›Full record

ArticlePloS one2013

Differential response of the cynomolgus macaque gut microbiota to Shigella infection.

Anna M Seekatz, Aruna Panda, David A Rasko, Franklin R Toapanta, Emiley A Eloe-Fadrosh, Abdul Q Khan, Zhenqiu Liu, Steven T Shipley, Louis J Detolla, Marcelo B Sztein and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. AttenuatedFrontiers in microbiology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Recent insights into Shigella.Current opinion in infectious diseases · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Anna M SeekatzInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Aruna Panda
David A Rasko
Franklin R Toapanta
Emiley A Eloe-Fadrosh
Abdul Q Khan
Zhenqiu Liu
Steven T Shipley
Louis J Detolla
Marcelo B Sztein
Claire M Fraser
University of Maryland, Baltimore · USUniformed Services University of the Health Sciences · US

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Wild-type S. typhi Infection in Humans: Integrated Immunoprotective MechanismsU19AI082655 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI GREENWALD, BRUCE D · 2009 to 2018
$27.8M
NCATS NIH HHS UL1 TR000124NIAID NIH HHS U19 AI082655
6 · The paper itself

Abstract

Little is known about the role of gut microbiota in response to live oral vaccines against enteric pathogens. We examined the effect of immunization with an oral live-attenuated Shigella dysenteriae 1 vaccine and challenge with wild-type S. dysenteriae 1 on the fecal microbiota of cynomolgus macaques using 16 S rRNA analysis of fecal samples. Multi-dimensional cluster analysis identified different bacterial community types within macaques from geographically distinct locations. The fecal microbiota of Mauritian macaques, observed to be genetically distinct, harbored a high-diversity community and responded differently to Shigella immunization, as well as challenge compared to the microbiota in non-Mauritian macaques. While both macaque populations exhibited anti-Shigella antibody responses, clinical shigellosis was observed only among non-Mauritian macaques. These studies highlight the importance of further investigation into the possible protective role of the microbiota against enteric pathogens and consideration of host genetic backgrounds in conducting vaccine studies.

Indexed as

VaccinationAdministration, OralAnimalsAntibodies, BacterialDysentery, BacillaryFecesFemaleGastrointestinal TractGenetic VariationHost-Pathogen InteractionsMacaca fascicularisMaleMicrobiotaMolecular TypingPhylogenyRNA, BacterialAntibodies, BacterialRNA, BacterialRNA, Ribosomal, 16SShigella VaccinesVaccines, Attenuated

Identifiers

PMID23755118
PMCPMC3673915
OpenAlexW2037403518

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.